JP2023535078A5 - - Google Patents

Info

Publication number
JP2023535078A5
JP2023535078A5 JP2023504653A JP2023504653A JP2023535078A5 JP 2023535078 A5 JP2023535078 A5 JP 2023535078A5 JP 2023504653 A JP2023504653 A JP 2023504653A JP 2023504653 A JP2023504653 A JP 2023504653A JP 2023535078 A5 JP2023535078 A5 JP 2023535078A5
Authority
JP
Japan
Prior art keywords
complex according
seq
antibody
oligonucleotide
consecutive nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023504653A
Other languages
English (en)
Japanese (ja)
Other versions
JP7894355B2 (ja
JP2023535078A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/040986 external-priority patent/WO2022026152A2/en
Publication of JP2023535078A publication Critical patent/JP2023535078A/ja
Publication of JP2023535078A5 publication Critical patent/JP2023535078A5/ja
Application granted granted Critical
Publication of JP7894355B2 publication Critical patent/JP7894355B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023504653A 2020-07-23 2021-07-09 筋緊張性ジストロフィーを処置するための筋標的化複合体およびその使用 Active JP7894355B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063055749P 2020-07-23 2020-07-23
US63/055,749 2020-07-23
US202063069075P 2020-08-23 2020-08-23
US63/069,075 2020-08-23
US202163143827P 2021-01-30 2021-01-30
US63/143,827 2021-01-30
PCT/US2021/040986 WO2022026152A2 (en) 2020-07-23 2021-07-09 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

Publications (3)

Publication Number Publication Date
JP2023535078A JP2023535078A (ja) 2023-08-15
JP2023535078A5 true JP2023535078A5 (cg-RX-API-DMAC7.html) 2024-07-18
JP7894355B2 JP7894355B2 (ja) 2026-07-23

Family

ID=80038121

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023504653A Active JP7894355B2 (ja) 2020-07-23 2021-07-09 筋緊張性ジストロフィーを処置するための筋標的化複合体およびその使用

Country Status (11)

Country Link
US (1) US20240016952A1 (cg-RX-API-DMAC7.html)
EP (1) EP4185383A4 (cg-RX-API-DMAC7.html)
JP (1) JP7894355B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230042713A (cg-RX-API-DMAC7.html)
CN (1) CN116438304A (cg-RX-API-DMAC7.html)
AU (1) AU2021318851A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023001126A8 (cg-RX-API-DMAC7.html)
CA (1) CA3186742A1 (cg-RX-API-DMAC7.html)
IL (1) IL299663A (cg-RX-API-DMAC7.html)
MX (1) MX2023000958A (cg-RX-API-DMAC7.html)
WO (1) WO2022026152A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12370264B1 (en) 2018-08-02 2025-07-29 Dyne Therapeutics, Inc. Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject
US11911484B2 (en) 2018-08-02 2024-02-27 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating myotonic dystrophy
US12097263B2 (en) 2018-08-02 2024-09-24 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating myotonic dystrophy
US12018087B2 (en) 2018-08-02 2024-06-25 Dyne Therapeutics, Inc. Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject
EP3830259A4 (en) 2018-08-02 2022-05-04 Dyne Therapeutics, Inc. MUSCLE TARGETED COMPLEXES AND THEIR USES IN THE TREATMENT OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
US11168141B2 (en) 2018-08-02 2021-11-09 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating dystrophinopathies
WO2020028832A1 (en) 2018-08-02 2020-02-06 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating dystrophinopathies
WO2021154477A1 (en) 2020-01-31 2021-08-05 Dyne Therapeutics, Inc. Anti-transferrin receptor (tfr) antibody and uses thereof
US11638761B2 (en) 2021-07-09 2023-05-02 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy
US11771776B2 (en) 2021-07-09 2023-10-03 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating dystrophinopathies
US11969475B2 (en) 2021-07-09 2024-04-30 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
AU2021313058A1 (en) * 2020-07-23 2023-03-30 Dyne Therapeutics, Inc. Muscle-targeting complexes and uses thereof
US11672872B2 (en) 2021-07-09 2023-06-13 Dyne Therapeutics, Inc. Anti-transferrin receptor antibody and uses thereof
US11633498B2 (en) 2021-07-09 2023-04-25 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating myotonic dystrophy
KR20230079068A (ko) * 2020-09-03 2023-06-05 다인 세라퓨틱스, 인크. 단백질-올리고뉴클레오티드 복합체의 제조 방법
AU2021414227A1 (en) * 2020-12-31 2023-07-06 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating myotonic dystrophy
WO2023283623A1 (en) 2021-07-09 2023-01-12 Dyne Therapeutics, Inc. Muscle targeting complexes and formulations for treating dystrophinopathies
US20250249117A1 (en) * 2022-04-15 2025-08-07 Dyne Therapeutics, Inc. Dosing of muscle targeting complexes for treating myotonic dystrophy
IL316143A (en) 2022-04-15 2024-12-01 Dyne Therapeutics Inc Muscle targeting complexes and formulations for the treatment of myotonic dystrophy
WO2023201324A1 (en) * 2022-04-15 2023-10-19 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating myotonic dystrophy
US20250352672A1 (en) * 2022-05-13 2025-11-20 University Of Washington Method for treatment of myotonic dystrophy combining protein expression and rna interference vector delivery with tissue detargeting
WO2025006955A2 (en) * 2023-06-30 2025-01-02 Ionis Pharmaceuticals, Inc. Cd29 targeted oligonucleotides and uses thereof
KR20260044219A (ko) 2023-07-21 2026-04-01 매로우 테라퓨틱스, 인크. 조혈 세포 표적화 접합체 및 관련 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011349443B2 (en) * 2010-12-20 2015-12-24 Genentech, Inc. Anti-mesothelin antibodies and immunoconjugates
US9598496B2 (en) * 2011-05-09 2017-03-21 Perseus Proteomics Inc. Antibody capable of specifically recognizing transferrin receptor
CA2990785C (en) * 2015-06-24 2024-11-12 Jcr Pharmaceuticals Co., Ltd. ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODIES CROSSING THE BLOOD-BRAIN BARRIER
FR3049951A1 (fr) * 2016-04-12 2017-10-13 Univ Rabelais Francois Nouvelles constructions peptidiques et leur utilisation dans le traitement de la toxoplasmose
KR20190014525A (ko) * 2016-05-27 2019-02-12 애브비 바이오테라퓨틱스 인크. 면역 조절 단백질과 종양 항원을 결합하는 이중특이적 결합 단백질
CN118638787A (zh) * 2017-12-06 2024-09-13 艾维迪提生物科学公司 治疗肌萎缩和强直性肌营养不良的组合物和方法
AU2019315593B2 (en) * 2018-08-02 2026-05-21 Dyne Therapeutics, Inc. Muscle-targeting complexes and uses thereof
EP3829594A4 (en) * 2018-08-02 2022-05-11 Dyne Therapeutics, Inc. MUSCLE TARGETING COMPLEXES AND THEIR USES FOR THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
CN112955154A (zh) * 2018-08-02 2021-06-11 达因疗法公司 肌肉靶向复合物及其用于治疗强直性肌营养不良的用途
CN112930193A (zh) * 2018-08-02 2021-06-08 达因疗法公司 肌肉靶向复合物及其在治疗肌肉萎缩中的用途
IL312067B2 (en) * 2018-12-21 2025-08-01 Avidity Biosciences Inc Anti-transferrin receptor antibodies and uses thereof

Similar Documents

Publication Publication Date Title
JP2023509793A5 (cg-RX-API-DMAC7.html)
JP2024503609A5 (cg-RX-API-DMAC7.html)
JP2025067909A5 (cg-RX-API-DMAC7.html)
JP2021533200A5 (cg-RX-API-DMAC7.html)
JP2024524222A5 (cg-RX-API-DMAC7.html)
JP2021533197A5 (cg-RX-API-DMAC7.html)
JP2023535444A5 (cg-RX-API-DMAC7.html)
JP2021532832A5 (cg-RX-API-DMAC7.html)
JP2021533199A5 (cg-RX-API-DMAC7.html)
JP2024501872A5 (cg-RX-API-DMAC7.html)
JP2024525614A5 (cg-RX-API-DMAC7.html)
JP2023512442A5 (cg-RX-API-DMAC7.html)
JP2023512441A5 (cg-RX-API-DMAC7.html)
JP2023535073A5 (cg-RX-API-DMAC7.html)
JP2023510351A5 (cg-RX-API-DMAC7.html)
JP7447073B2 (ja) Pd-l1発現低減用のオリゴヌクレオチド
JP2023535074A5 (cg-RX-API-DMAC7.html)
JP2024160045A5 (cg-RX-API-DMAC7.html)
JP2021533198A5 (cg-RX-API-DMAC7.html)
JP2023510350A5 (cg-RX-API-DMAC7.html)
JP2024546436A5 (cg-RX-API-DMAC7.html)
JP2024527362A5 (cg-RX-API-DMAC7.html)
JP2025512468A5 (cg-RX-API-DMAC7.html)
IL309910A (en) Muscle targeting complexes and their uses for the treatment of myotonic dystrophy
JP2021532831A5 (cg-RX-API-DMAC7.html)